Learn more

IDORSIA PHARMACEUTICALS LTD

Overview
  • Total Patents
    671
  • GoodIP Patent Rank
    2,525
  • Filing trend
    ⇧ 80.0%
About

IDORSIA PHARMACEUTICALS LTD has a total of 671 patent applications. It increased the IP activity by 80.0%. Its first patent ever was published in 2003. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are SHENZHEN CHIPSCREEN BIOSCIENCES LTD, KASINA LAILA INNOVA PHARMACEUTICALS PRIVATE LTD and MEDIVATION TECHNOLOGIES INC.

Patent filings per year

Chart showing IDORSIA PHARMACEUTICALS LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Boss Christoph 127
#2 Sifferlen Thierry 103
#3 Von Raumer Markus 93
#4 Richard-Bildstein Sylvia 87
#5 Fretz Heinz 79
#6 Pothier Julien 67
#7 Surivet Jean-Philippe 67
#8 Heidmann Bibia 66
#9 Lyothier Isabelle 65
#10 Corminboeuf Olivier 61

Latest patents

Publication Filing date Title
WO2021038068A1 Alpha-d-galactopyranoside derivatives
WO2021028570A1 2-hydroxycycloalkane-1-carbamoyl derivatives
WO2021028336A1 (hetero)aryl-methyl-thio-beta-d-galactopyranoside derivatives
WO2021028323A1 (2-acetamidyl)thio-beta-d-galactopyranoside derivatives
WO2021009212A1 Antibacterial quinolone derivatives
WO2021005222A1 Inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan 2,3-dioxygenase
WO2021005101A1 Pharmaceutical composition comprising a tetrahydropyrazolopyrimidinone compound
WO2020254408A1 Pyridin-3-yl derivatives
WO2020225077A1 Pyrimido[4,5-b]indol derivatives as pdhk1 inhibitors
WO2020099511A1 Benzimidazole-2-methyl-morpholine derivatives
WO2020007964A1 2-(2-azabicyclo[3.1.0]hexan-1-yl)-1h-benzimidazole derivatives
WO2020007977A1 7-trifluoromethyl-[1,4]diazepan derivatives
WO2019229010A1 Device and method for dispensing at least one substance
ZA201902553B Crystalline forms
TW201932460A Crystalline forms of (3S,4S)-1-cyclopropylmethyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amide
US2020347029A1 C5a receptor modulators
CN111683937A C5a receptor modulators
EP3740493A1 Inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan 2,3-dioxygenase
AR114564A1 DERIVATIVES OF 2,4,6,7-TETRAHIDRO-PIRAZOLO [3,4-D] PYRIMIDIN-ONA AS MODULATORS OF THE C5a RECEPTOR AND THE PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM
CA3083327A1 Combination of a 4-pyrimidinesulfamide derivative with an sglt-2 inhibitor for the treatment of endothelin related diseases